{"id":"NCT00346034","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"This Study is An Open-Label Trial Of Pregabalin In Patients With Fibromyalgia","officialTitle":"A 12 Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2008-02","completion":"2008-02","firstPosted":"2006-06-29","resultsPosted":"2009-03-13","lastUpdate":"2021-01-22"},"enrollment":357,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Fibromyalgia"],"interventions":[{"type":"DRUG","name":"Pregabalin","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"The main purpose of this protocol is to evaluate the long-term safety of pregabalin in patients who participated in the previous fibromyalgia Study A0081100 and who wish to receive open-label pregabalin therapy.","primaryOutcome":{"measure":"Change From Baseline to Week 4 in Pain Visual Analog Scale (VAS) Score","timeFrame":"Week 4","effectByArm":[{"arm":"Pregabalin","deltaMin":-18.1,"sd":24.1}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":51,"countries":["Canada","Denmark","France","Germany","India","Italy","Netherlands","Portugal","South Korea","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":["22503162"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081101&StudyName=This%20Study%20is%20An%20Open-Label%20Trial%20Of%20Pregabalin%20In%20Patients%20With%20Fibromyalgia%20%20%20"]},"adverseEventsSummary":{"seriousAny":{"events":6},"commonTop":["Dizziness","Headache","Somnolence","Fatigue","Nausea"]}}